Innovation1 Biotech Inc.

IVBT

US39809D2018

Investment Holding Companies

Delayed OTC Markets Other stock markets 14:31:07 19/04/2024 BST			5-day change	1st Jan Change
0.0008 ^USD	-96.36%		-.--%	-99.07%

01-17	Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	CI
2023	Innovation1 Biotech Inc. announced that it has received $0.15 million in funding	CI

Gridiron Bionutrients, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019

January 21, 2020 at 11:20 am

Gridiron BioNutrients, Inc. announced earnings results for the first quarter ended November 30, 2019. For the first quarter, the company announced sales was USD 633 compared to USD 1,128 a year ago. Operating loss was USD 57,102 compared to USD 191,598 a year ago. Net loss was USD 269,849 compared to USD 91,408 a year ago.

Latest news about Innovation1 Biotech Inc.

Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	01-17	CI
Innovation1 Biotech Inc. announced that it has received $0.15 million in funding	12-05	CI
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	10-31	CI
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	10/10/23	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	13/09/23	CI
Innovation1 Biotech Inc. announced that it has received $0.066891 million in funding	31/08/23	CI
Innovation1 Biotech Inc. Announces Resignation of Patrick Morris as Chairman of the Board	11/08/23	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	30/05/23	CI
Innovation1 Biotech Inc. Announces Resignation of Jeffrey Kraws as a Director	24/04/23	CI
Innovation1 Biotech Inc. announced that it expects to receive $0.28 million in funding from Cavalry Fund I Management, LLC, Lincoln Park Capital, LLC, L1 Capital Pty. Limited	12/04/23	CI
Innovation1 Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	17/01/23	CI
Innovation1 Biotech Inc. announced that it has received $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC	26/12/22	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	15/12/22	CI
Innovation1 Biotech Inc. Auditor Raises 'Going Concern' Doubt	14/12/22	CI
Innovation1 Biotech Inc. Announces Board Appointments	12/12/22	CI
Innovation1 Biotech Inc. announced that it expects to receive $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC	28/11/22	CI
Innovation1 Biotech Inc. Announces the Resignation of Andrew Salzman as Chief Science Officer	17/11/22	CI
Ingenius Biotech S.L. acquired All Of The Assets Relating to Mioxal from Innovation1 Biotech Inc. for $0.1 million.	13/11/22	CI
Innovation1 Biotech Inc. Announces Resignation of Andrew Salzman	25/10/22	CI
Innovation1 Biotech Inc. Appoints Frederick E. Pierce, Ii to Its Board of Directors	15/09/22	CI
Innovation1 Biotech Inc. Announces Filing of Patent Application for Novel Combination Therapy Targeting Addiction	18/08/22	CI
Innovation1 Biotech Inc. Appoints Andrew L. Salzman, M.D., to Its Board of Directors	11/08/22	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2022	14/07/22	CI
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2022	15/04/22	CI
Innovation1 Biotech, Inc. Announces Director Changes	08/04/22	CI

Chart Innovation1 Biotech Inc.

Duration

Period

More charts

Company Profile

Innovation1 Biotech Inc. is a shell company. The Company has no operations and is evaluating a number of strategic alternatives including, but not limited to, seeking to acquire a new business in the United States, including potentially by means of a reverse merger with an operating entity. The Company has no sources of revenue.

Sector

Investment Holding Companies

More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

	1st Jan change	Capi.
INNOVATION1 BIOTECH INC.	-99.07%	17.98K
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+107.43%	7.01B
CHURCHILL CAPITAL CORP VII	+2.71%	987M
PERELLA WEINBERG PARTNERS	+52.66%	976M
ARES ACQUISITION CORPORATION II	+2.54%	669M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
E7 GROUP	-2.15%	593M
ADMIRAL ACQUISITION LIMITED	+10.28%	536M
CAPITOL INVESTMENT CORP. VII	-.--%	500M
AEA-BRIDGES IMPACT CORP.	+6.81%	470M